Industry News
Pharmaceutical Industry News
In a first, FDA approves topical sirolimus for rare disease lesions
In a first, FDA approves topical sirolimus for rare disease lesions ntaylor Tue, 04/05/2022 - 06:28
Ukraine war, China’s COVID lockdown and more could weigh on J&J’s early-year performance—and it may not be alone: analysts
Ukraine war, China's COVID lockdown and more could weigh on J&J's early-year performance—and it may not be alone: analysts fkansteiner Mon, 04/04/2022 - 14:27
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patients
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patients kdunleavy Mon, 04/04/2022 - 12:53
Sanofi, Regeneron score fast FDA review for Dupixent in eosinophilic esophagitis
Sanofi, Regeneron score fast FDA review for Dupixent in eosinophilic esophagitis kdunleavy Mon, 04/04/2022 - 11:08
Alnylam’s Onpattro follow-on delayed thanks to manufacturing holdup at FDA
Alnylam's Onpattro follow-on delayed thanks to manufacturing holdup at FDA fkansteiner Mon, 04/04/2022 - 10:25
Sanofi launches DE&I board with outside advisors, the first of its kind in pharma
Sanofi launches DE&I board with outside advisors, the first of its kind in pharma kdunleavy Mon, 04/04/2022 - 09:23
Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double production—again
Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double production—again fkansteiner Mon, 04/04/2022 - 08:41
In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs
In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs aliu Mon, 04/04/2022 - 04:30
Imfinzi maker AstraZeneca adds caregivers to refreshed ‘Notes’ campaign for lung cancer patients
Imfinzi maker AstraZeneca adds caregivers to refreshed 'Notes' campaign for lung cancer patients nmissakian Sun, 04/03/2022 - 15:06
ACC: Lexicon hopes sotaglifozin cardio data will set its drug apart from SGLT2 rivals
ACC: Lexicon hopes sotaglifozin cardio data will set its drug apart from SGLT2 rivals kdunleavy Sat, 04/02/2022 - 15:00
ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals
ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals kdunleavy Sat, 04/02/2022 - 15:00
Key Success Metrics for Clinical Development Organizations
Key Success Metrics for Clinical Development Organizations mwen Fri, 04/01/2022 - 16:01
Amid Exkivity launch, Takeda beefs up in-house digital content team, AI to educate oncologists
Amid Exkivity launch, Takeda beefs up in-house digital content team, AI to educate oncologists nmissakian Fri, 04/01/2022 - 14:13
Viatris, after closing massive West Virginia plant, sells it for $1
Viatris, after closing massive West Virginia plant, sells it for $1 kdunleavy Fri, 04/01/2022 - 11:18
Pfizer asks hourly staffers to return overpayments in aftermath of vendor’s cyberattack: reports
Pfizer asks hourly staffers to return overpayments in aftermath of vendor's cyberattack: reports fkansteiner Fri, 04/01/2022 - 10:59
Bristol Myers CEO Caforio takes pay cut as ‘human capital’ metric drags down bonus
Bristol Myers CEO Caforio takes pay cut as 'human capital' metric drags down bonus aliu Fri, 04/01/2022 - 10:26
Bristol Myers CEO Giovanni Caforio takes pay cut as ‘human capital’ metric drags down bonus
Bristol Myers CEO Giovanni Caforio takes pay cut as 'human capital' metric drags down bonus aliu Fri, 04/01/2022 - 10:26
After pocketing $18.9M, Seagen’s Clay Siegall could reclaim spot among best-paid biopharma CEOs
After pocketing $18.9M, Seagen's Clay Siegall could reclaim spot among best-paid biopharma CEOs fkansteiner Fri, 04/01/2022 - 09:19
Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use
Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use kdunleavy Fri, 04/01/2022 - 09:13
Sanofi’s CDMO spinoff set for next month as new group targets 2022 revenues of €1B
Sanofi's CDMO spinoff set for next month as new group targets 2022 revenues of €1B esagonowsky Fri, 04/01/2022 - 08:21